Metoprolol Teva (Metoprolol Tartrate)

Metoprolol Teva is a selective β1‑blocker that acts on the cardiovascular system to control blood pressure and heart workload.

• Hypertension: lowers systemic blood pressure by reducing heart rate and myocardial contractility.
• Angina pectoris: decreases myocardial oxygen demand, relieving chest pain.
• Post‑myocardial infarction: improves survival by limiting cardiac stress after an infarct.
• Heart failure: reduces ventricular remodeling and improves functional capacity.
• Cardiac arrhythmias: controls abnormal heart rhythms by slowing conduction through the AV node.

• Metoprolol tartrate selectively antagonizes β1‑adrenergic receptors in cardiac tissue, leading to decreased heart rate, reduced myocardial contractility, and lower cardiac output. The blockade also diminishes renin release from the kidneys, contributing to a modest reduction in systemic vascular resistance and blood pressure.

Metoprolol Teva may cause a range of adverse reactions.

Common Side Effects

• Fatigue: feeling of tiredness or lack of energy.
• Dizziness: light‑headed sensation, especially when standing quickly.
• Bradycardia: slower than normal heart rate.
• Cold extremities: reduced blood flow to hands and feet.
• Headache: mild to moderate pain in the head.
• Gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects

• Severe bradycardia or heart block: may require medical attention.
• Hypotension: markedly low blood pressure causing faintness.
• Bronchospasm: constriction of airways, particularly in patients with asthma.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.
• Depression or mood changes: worsening of depressive symptoms.
• Cardiac failure exacerbation: worsening of existing heart failure.

Before prescribing Metoprolol Teva, clinicians should evaluate patient-specific factors and monitor for adverse events.

• Assess cardiovascular status: obtain baseline heart rate and blood pressure.
• Avoid abrupt discontinuation: taper dose under medical supervision to prevent rebound tachycardia.
• Use caution in asthma or COPD: monitor for bronchospasm despite β1 selectivity.
• Adjust for renal or hepatic impairment: consider dose reduction in compromised patients.
• Store at ambient temperature: keep in original container, protect from moisture and light.

Metoprolol Teva can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Co‑administration with other β‑blockers: additive bradycardia and AV block.
• Non‑dihydropyridine calcium channel blockers (verapamil, diltiazem): risk of severe bradycardia.
• Clonidine: may cause rebound hypertension if stopped abruptly.

Moderate Interactions (Monitor Closely)

• Diuretics (especially thiazides): enhanced hypotensive effect.
• ACE inhibitors or ARBs: additive blood pressure lowering.
• Antidiabetic agents: may mask hypoglycemia symptoms.
• Antidepressants (e.g., SSRIs): potential for increased plasma levels of metoprolol.